Abstract
This chapter describes the principles and practices of quality management of the steroid hormone in clinical laboratory service, and the assessment of the quality of that service by the author’s EQA programme (UK NEQAS for Steroid Hormones).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barnard G, Kohen F (1990) Idiometric assay: noncompetitive immunoassay for small molecules typified by the measurement of oestradiol in serum. Clin. Chem. 36; 1945–1950.
Büttner J (1991) Philosophy of measurement by means of immunoassays. Scand. J. Clin. Lab. Invest. 51 (Suppl 205); 11–20.
Cawood ML, Field HP, Ford CG, Gillingwater S, Kicman A, Cowan D, Barth JH (2005) Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clin. Chem. 51, 1472–1479.
de Verdier CH, Groth T, Petersen PH (eds) (1993) Medical Need for quality specifications in clinical laboratories. Upsala J. Med. Sci. 98(3); 189–498.
Ekins R (1983) The precision profile: its use in assay design, assessment and quality control. In Immunoassays for Clinical Chemistry (eds Hunter WM, Corrie JET). Churchill-Livingstone, Edinburgh. pp. 76–105.
Ekins R (1991a) Immunoassay standardisation. Scand. J. Clin. Lab. Invest. 51(Suppl 205); 33–46.
Ekins R (1991b) Immunoassay design and optimisation. In Principles and Practice of Immunoassay (eds Price C, Newman D), Chapter 5. Macmillan, London. pp. 96–153.
Ekins RP, Chu R, Biggart E (1990) The development of microspot, multi-analyte, ratiometric immunoassay using dual fluorescent-labelled antibodies. Anal. Chim. Acta. 227; 73–96.
EU Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices (1998-12-07 OJ No L 331/1).
Fraser CG (1983) Desirable performance standards for clinical chemistry tests. Adv. Clin. Chem. 23; 299–339.
Fraser CG, Hyltoft-Petersen P (1993a) Desirable standards for laboratory tests if they are to fulfil medical needs. Clin. Chem. 39; 1447–1455.
Fuentes-Aderiu X (2000) Trueness and Uncertainty website guest essay at www.westgard.com/guest15.htm
Gosling JP (1991) Standardisation of immunoassays for Hapten analytes. Scand. J. Clin. Lab. Invest. 51 (Suppl 205); 95–104.
Gosling JP, Middle JG, Siekmann L, Read GF (1993) Standardisation of Hapten immunoprocedures: total cortisol. Scand. J. Clin. Lab. Invest. 53 (Suppl 216); 3–41.
Hammond GL (1990) Molecular properties of corticosteroid binding globulin and the sex steroid binding proteins. Endocr.Rev. 11; 65–79.
Healy MJR (1979) Outliers in clinical chemistry quality control schemes. Clin. Chem. 25; 675–677.
Herold DA, Fitzgerald RL (2003) Immunoassays for testosterone in women: better than a guess? Clin. Chem. 49; 1250–1251.
Hyltoft Petersen P, Horder M (1992) Influence of analytical quality on test results. Scand. J. Clin. Lab. Invest. 52 (Suppl 208); 65–67.
Jeffcoate SL (1981) Efficiency and Effectiveness in the Clinical Laboratory. Academic, London.
Kane J, Middle J, Cawood M (2007) Measurement of serum testosterone in women; what should we do? Ann. Clin. Biochem. 44; 5–15.
Kushnir MM, Rockwood AL, Roberts WL, Pattison EG, Bunker AM, Fitzgerald RL, and Meikle AW (2006) Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin. Chem. 52; 120–128.
Libeer J-CPM (1993) External Quality Assessment in Clinical Laboratories – European perspectives: today and tomorrow. Ph.D. thesis, University of Antwerp, Belgium.
Middle JG (1998) Standardisation of steroid hormone assays. Ann. Clin. Biochem. 35; 354–363.
Middle JG (2007) Dehydroepiandrostenedione sulphate interferes in many direct immunoassays for testosterone. Ann. Clin. Biochem. 44; 173–177.
Middle JG, Libeer JC, Malakhov V, Penttilä I (1998) Characterisation and evaluation of external quality assessment scheme serum. Discussion Paper from the European External Quality Assessment (EQA) Organisers Working Group C. Clin. Chem. Lab. Med. 36; 119–130.
Panteghini M (2007) Traceability, reference systems and result comparability. Clin. Biochem. Rev. 28; 97–104.
Ratcliffe WA, Carter GD, Dowsett M, Hillier SG, Middle JG, Reed MJ (1988) Oestradiol assays: applications and guidelines for the provision of a clinical biochemistry service. Ann. Clin. Biochem. 25; 466–483.
Ricos C, Arbos MA (1990) Quality goals for hormone testing. Ann. Clin. Biochem. 27; 353–358.
Ricós C, Iglesias N, GarcÃa-Lario JV, Simón M, Cava F, Hernández A, Perich C, Minchinela J, Alvarez V, Doménech MV, Jiménez CV, Biosca C, Tena R (2007) Within-subject biological variation in disease: collated data and clinical consequences. Ann. Clin. Biochem. 44; 343–352.
Ritchie RF (1991) Immunoanalytical standardization – a global science. Scand. J. Clin. Lab. Invest. Suppl. 205; 3–10.
Selby C (1990) Sex hormone binding globulin: origin, function and clinical significance. Ann. Clin. Biochem. 27; 532–541.
Seth J, Hanning I (1988) Factors associated with the quality of laboratory performance in the United Kingdom external quality assessment scheme for serum growth hormone. Clin. Chim. Acta. 174; 185–196.
Stanczyk FZ, Lee JS, Santen RJ. (2007) Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiol. Biomarkers Prev. Sep; 16(9);1713–1719.
Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P (2003) Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin. Chem. 49; 1381–1395.
Thienpont LM, Van Uytfanghe K, De Leenheer AP (2002) Reference measurement systems in clinical chemistry. Clin. Chim. Ada. 323; 73–87.
Westgard JO, Darcy T (2004) The truth about quality: medical usefulness and analytical reliability of laboratory tests. Clin. Chim. Acta. 346; 3–11.
Westgard JO, Petersen JH, Groth T (1984) The quality costs of an analytical process: development of quality costs models based on predicitive value theory. Scand. J. Clin. Lab. Invest. 44(Suppl 172); 221–236.
Acknowledgments
The UK NEQAS for Steroid Hormones is funded by subscriptions from participants throughout the UK and overseas. Administrative support is provided by the staff of the Wolfson EQA Laboratory, part of the University Hospital Birmingham NHS Foundation Trust, directed by Dr. David Bullock. Scientific guidance is provided by the UK NEQAS Special Advisory Group for Immunoassay (Chair Dr. Geoff Beckett). Policy support is given by the UK NEQAS Consortium Executive (chair Mrs Barbara De La Salle). UK NEQAS could not function without the support of the National Blood Service at Birmingham, and the work of the Wolfson Computer Laboratory, University Hospital Birmingham NHS Foundation Trust, directed by Dr. Ian Clarke, in developing and maintaining the EQAS Computer System, which is warmly acknowledged.
It should be noted that Siemens Healthcare Medical Solutions have now absorbed Bayer Diagnostics and the Diagnostic Products Corporation. Therefore all references to method names such as Bayer Centaur and DPC Immulite should be understood now to mean Siemens Centaur and Siemens Immulite.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Middle, J.G. (2010). Quality Management of Steroid Hormone Assays. In: Makin, H., Gower, D. (eds) Steroid Analysis. Springer, Dordrecht. https://doi.org/10.1023/b135931_13
Download citation
DOI: https://doi.org/10.1023/b135931_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9774-4
Online ISBN: 978-1-4020-9775-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)